BETA2025-10-012025-12-31BETA2025-12-31BETA2025-04-012025-12-31BETA2025-10-012025-12-31in-capmkt:OtherExpenses1MemberBETA2025-04-012025-12-31in-capmkt:OtherExpenses1Member0000002025-12-31Statement10000002025-10-012025-12-31Statement1BETA2025-12-31StatementDynamic1I1Statement1BETA2025-12-31StatementDynamic1I2Statement1BETA2025-12-31StatementDynamic1I3Statement1BETA2025-12-31StatementDynamic1I4Statement1BETA2025-12-31StatementDynamic1I5Statement1BETA2025-12-31StatementDynamic1I6Statement1BETA2025-12-31StatementDynamic1I7Statement1BETA2025-12-31StatementDynamic1I8Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000BETANOTLISTEDINE351Y01019BETA DRUGS LIMITEDMain BoardEquity2025-04-012026-03-312026-02-142026-02-10INRLakhsQuarterlyThird quarterSingle segmentPHARMACEUTICAL2026-02-1411:00:002026-02-1413:25:00Not applicabletrue1false.2025-10-012025-12-31UnauditedStandalone5027630002507200052783500024722100001419900082418000317160002509200093454000494100000337350000337350002169000-9600001209000032526000000032526000032526000101368000103.213.21003.213.211. The above results have been reviewed by the Audit Committee and taken on record by Board of Directors at their respective meetings held on 14th February, 2026. <BR> 2. The company is engaged in single business segment i.e. Pharmaceuticals. <BR> 3. Figures are regrouped/rearranged, wherever considered necessary. <BR> 2025-04-012025-12-31UnauditedStandalone17108140008225500017930690009918770000694600024740800089328000692940002766940001681547000111522000011152200024207000-269300021514000090008000000090008000090008000101368000108.888.88008.888.88Other Expenses93454000Other Expenses276694000000000Preferential Issues2024-11-2511701450002025-12-31trueBrickwork Ratings India Private LimitedfalseNANilNilRAJNI BRARCompany Secretary and Compliance OfficerPANCHKULA2026-02-14Facility Upgradation of 100% Subsidiary - Adley Formualtions Pvt Ltd.NA800000000225000000Facility Upgradation of 100% Subsidiary - Adley Lab Ltd.NA500000000135000000R & D facilty (new setup)NA150000000095000000Geographical Expansion NA100000000000Capital Expenditure (Manufacturing- new setup)NA4400000000952000000Capital Investment (including capital acquisitions)NA200000000000General Corporate PurposeNA1500000000671000000Any other purpose as approved by BoardNA0000